EV/EBITDA:
51.99+0.39(+0.76%)Summary
- As of today (September 17, 2025), TGTX EV/EBITDA is 51.99, with a rise of +0.39 (+0.76%) during the most recent trading session on September 16, 2025.
- Over the past year, TGTX EV/EBITDA has increased by +17.46 (+50.56%).
- TGTX EV/EBITDA is now -94.24% below its all-time high of 903.07.
Performance
TGTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TGTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.8% | +0.8% | +0.8% |
| 1 m1 month | +13.9% | +13.9% | +13.9% |
| 3 m3 months | -34.8% | -9.9% | -10.2% |
| 6 m6 months | -59.1% | -20.1% | -21.7% |
| ytdytd | -43.9% | +9.6% | +6.3% |
| 1 y1 year | +50.6% | +35.4% | +28.5% |
| 5 y5 years | +454.2% | +74.4% | +28.8% |
TGTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 52.76 | -1.5% | 45.07 | +15.3% |
| 3 m | 3-month | 84.99 | -38.8% | 42.90 | +21.2% |
| 6 m | 6-month | 133.82 | -61.1% | 42.90 | +21.2% |
| 1 y | 1-year | 903.07 | -94.2% | 32.19 | +61.5% |
| 3 y | 3-year | 903.07 | -94.2% | -72.04 | +172.2% |
| 5 y | 5-year | 903.07 | -94.2% | -72.04 | +172.2% |
| alltime | all time | 903.07 | -94.2% | -72.04 | +172.2% |
TGTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 51.99(-43.9%) |
| 2024 | 92.61(-2.5%) |
| 2023 | 95.00(-1324.2%) |
| 2022 | -7.76(+6.7%) |
| 2021 | -7.27(-70.6%) |
| 2020 | -24.76(+262.5%) |
| 2019 | -6.83(+290.3%) |
| 2018 | -1.75(-62.2%) |
| Date | Value |
|---|---|
| 2017 | -4.63(+52.8%) |
| 2016 | -3.03(-67.6%) |
| 2015 | -9.34(-20.7%) |
| 2014 | -11.78(+144.9%) |
| 2013 | -4.81(+48.9%) |
| 2012 | -3.23(+7975.0%) |
| 2011 | -0.04(-99.2%) |
| 2010 | -5.13 |
FAQ
- What is TG Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for TG Therapeutics, Inc.?
- What is TGTX EV/EBITDA year-to-date change?
- What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
What is TG Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TGTX is 51.99
What is the all time high EV/EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high EV/EBITDA is 903.07
What is TGTX EV/EBITDA year-to-date change?
TG Therapeutics, Inc. EV/EBITDA has changed by -40.62 (-43.86%) since the beginning of the year
What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TGTX EV/EBITDA has changed by +17.46 (+50.56%)